Global Phase 2/3 Clinical Development Leader

Scorpion Therapeutics; United States; On-site; USD 180,000 - 240,000; Full time

Job summary

Scorpion Therapeutics in the United States is seeking a lead clinical development leader to oversee global Phase 2/3 programs, guiding trial design and execution to support NDA/BLA submissions.

You will drive cross-functional collaboration, supervise regulatory engagement, and ensure rigorous data collection and study documentation to advance late-stage programs in immunology and inflammation.

Qualifications

• PhD, PharmD, or equivalent.
• 8-10 years of experience in clinical research/development, managing Phase 3 studies in an FDA-regulated environment.
• Strong knowledge of GCP and ICH guidelines.
• Excellent communication and scientific writing skills.

Responsibilities

• Direct scientific design of trials.
• Serve as primary clinical representative on study teams.
• Develop data collection and monitoring strategies.
• Review study documentation.
• Prepare clinical training.
• Engage with regulatory authorities and external stakeholders.

Skills

GCP knowledge

ICH guidelines

Scientific writing

Excellent communication

Education

PhD, PharmD, or equivalent

Job description

Scorpion Therapeutics in the United States is seeking a lead clinical development leader to oversee global Phase 2/3 programs, guiding trial design and execution to support NDA/BLA submissions.

You will drive cross-functional collaboration, supervise regulatory engagement, and ensure rigorous data collection and study documentation to advance late-stage programs in immunology and inflammation.